LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)
Delgocitinib is not approved for use in patients aged 12-17 years, and the efficacy and safety in this…
Browsing Tag
delgocitinib
1 post